PeterIKarachunskiMD
Child Neurology • Minneapolis, MNAssociate Professor, Pediatric neurology University of Minnesota Medical School
Dr. Karachunski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
420 Delaware Street Se
Moos tower 13-240 MMC 295
Minneapolis, MN 55455Phone+1 612-626-2499Fax+1 612-273-0886- Is this information wrong?
Education & Training
University of MinnesotaFellowship, Child Neurology, 2002 - 2005- University of MinnesotaResidency, Pediatrics, 2000 - 2003
Russian State Medical UniversityClass of 1987
Certifications & Licensure
MN State Medical License 2005 - 2025- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2005 Dec 01
- Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping Start of enrollment: 2012 Apr 01
- Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Systemic under treatment of heart disease in patients with Duchenne muscular dystrophy.Peter Karachunski, DeWayne Townsend> ;Neuromuscular Disorders. 2023 Oct 1
- A comprehensive study of skeletal muscle imaging in FHL1-related reducing body myopathy.Payam Mohassel, Pomi Yun, Safoora Syeda, Abhinandan Batra, Andrew J Bradley, Sandra Donkervoort, Soledad Monges, Julie S Cohen, Doris G Leung, Francina Munell, Carlos ...> ;Annals of Clinical and Translational Neurology. 2023 Aug 1
- 5 citationsMeta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy.Perry B. Shieh, Gary Elfring, Panayiota Trifillis, Claudio Santos, Stuart W. Peltz, Julie A. Parsons, Susan D. Apkon, Basil T. Darras, Craig Campbell, Craig M. McDonal...> ;Journal of Comparative Effectiveness Research. 2021 Oct 25
- Join now to see all
Journal Articles
- TANGO2: Expanding the Clinical Phenotype and Spectrum of Pathogenic VariantsJennifer N Dines, Heather C Mefford, Barbara Burton, Joline Dalton, Alice Basinger, Peter Karachunski, Can Ficicioglu, Katherine L Helbig, Nature
Press Mentions
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingMay 26th, 2020
Toddler Who Got World’s Most Expensive Drug WalksFebruary 25th, 2020
Toddler with Fatal Muscle Condition ‘Recovers’ After $2m Infusion of World’s Most Expensive DrugFebruary 25th, 2020- Join now to see all
Hospital Affiliations
M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota- Shriners Hospitals for Children-Twin CitiesMinneapolis, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
